On February 3, 2020 AskAt reported that it received a notice of allowance dated January 22, 2020 from the Mexican Institute of Industrial Property (IMPI: Instituto Mexicano de la Propiedad Industrial) in connection with the Company’s Mexican Patent Application No. MX/a/2014/004566, a formulation patent for its COX-2 inhibitor (AAT-076) (Press release, AskAt, FEB 3, 2020, View Source [SID1234553760]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!